文献速递肾移植肾小球疾病

移植性肾小球炎的异质性与同种抗体的关系

The Diversity of Transplant Glomerulitis and its Relationship to Alloantibody.
PubMed 文献 · Kidney Int Rep · 2026-02-25

该研究对比271例Banff 1997定义的肾小球炎与612例无肾小球炎排斥及1442例正常对照,发现肾小球炎病因异质,38.0%与致敏相关,DSA+者炎症和慢性化更重且功能恶化,DSA-者多与TCMR相关且预后较好。

要点

  • 肾小球炎并非均提示抗体介导排斥,DSA阴性者常见TCMR或先天细胞炎症。
  • DSA+肾小球炎更易出现C4d+、慢性损伤和治疗抵抗,功能恶化风险高。
  • 孤立性肾小球炎多经监测活检发现,CD3+常见,预后优于伴炎症者。

核心结论

  • 肾小球炎是异质性病变,常提示AMR,但许多DSA和/或C4dptc阴性病例由TCMR或先天细胞炎症所致。

研究设计与样本

  • 回顾性比较Banff 1997定义的肾小球炎271例(来自4300例活检)与无肾小球炎排斥612例及正常对照1442例。

主要发现

  • 肾小球炎与致敏相关占38.0%,缺血内皮损伤占20.7%,医源性最小化占30.3%,不依从占21.4%。
  • Banff g评分与DSA+、C4dptc+、C4dglom+、cg、i、t、ti评分、血肌酐和蛋白尿相关。
  • DSA+肾小球炎以炎症、慢性瘢痕、C4d+、较晚出现、治疗抵抗和功能恶化为特征(P < 0.001 vs. DSA-)。
  • C4dptc-肾小球炎病因分类为TCMR 36.8%、纯AMR 28.1%、混合AMR 31.3%。
  • 孤立性肾小球炎占20.3%,70.9%经监测采样诊断,CD3+占51.9%,移植预后优于伴炎症者。

关键数值与推荐

  • DSA+肾小球炎与DSA-相比功能恶化P < 0.001。
  • 肾小球炎合并g0REJ者比正常对照更易失败(P < 0.001)。
  • 多变量Cox回归显示移植物存活独立决定于DSA+、C4dptc+、移植肾小球病和慢性间质纤维化,而非肾小球炎评分。

临床怎么用

  • 评估肾小球炎时应结合DSA和C4dptc状态,避免将所有肾小球炎等同于AMR。
  • DSA+肾小球炎提示治疗抵抗和功能恶化风险,需更积极管理。
  • DSA-且C4dptc-的肾小球炎应考虑TCMR或先天细胞炎症可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Although transplant glomerulitis often signifies antibody-mediated rejection (AMR), the pathophysiology of complement degradation split-product 4d (C4d) staining of peritubular capillaries (C4dptc) and donor-specific antibodies (DSAs) negative cases is unclear. METHODS: We compared Banff 1997 defined glomerulitis (n = 271, from 4300 biopsies) using serological and pathological dichotomization, against rejection without glomerulitis (g0REJ, n = 612) and normal controls (NIL, n = 1442). RESULTS: Epidemiological risk factors were female recipients, living donation, early T-cell-mediated rejection (TCMR) or AMR, and previous corticosteroid rejection treatment. Glomerulitis associated with sensitization in 38.0%, ischemic endothelial injury in 20.7%, iatrogenic minimization in 30.3%, and nonadherence in 21.4%. Banff g score correlated with DSA+, C4dptc+, endothelial C4d staining of glomerular capillaries positive (C4dglom+), Banff cg, i, t, ti scores, serum creatinine, and proteinuria. DSA+ glomerulitis was typified by inflammation, chronic scarring, C4d+, later presentation, treatment resistance, and functional deterioration (P < 0.001 vs. DSA-). DSA- glomerulitis from CD3+ TCMR (pure 43.3% and mixed 28.7% with AMR) presented earlier with excellent graft outcomes. C4dptc- glomerulitis was etiologically classified TCMR in 36.8%, pure AMR in 28.1%, and mixed AMR in 31.3%. Isolated glomerulitis in 20.3% was diagnosed by surveillance sampling in 70.9%, displayed CD3+ in 51.9% and a distinct but minimal spatial transcriptomic phenotype, with superior allograft outcomes compared with glomerulitis with inflammation. Kidneys with glomerulitis and g0REJ failed more frequently than normal control samples (P < 0.001). Graft survival was independently determined by DSA+, C4dptc+, transplant glomerulopathy, and chronic interstitial fibrosis using multivariable Cox regression, but not by glomerulitis score. CONCLUSION: Glomerulitis is a heterogenous biological lesion that frequently signifies AMR, however TCMR or innate cellular inflammation caused many DSA- and/or C4dptc- episodes.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Nankivell BJ, Viswanathan S, Ding X, et al. The Diversity of Transplant Glomerulitis and its Relationship to Alloantibody. Kidney Int Rep. 2026. PMID: 42006197. doi:10.1016/j.ekir.2026.106378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。